Constantine Davides
Stock Analyst at JMP Securities
(1.11)
# 3,605
Out of 4,865 analysts
98
Total ratings
33.33%
Success rate
-19.95%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Market Outperform | $110 → $117 | $100.01 | +16.99% | 5 | Jun 4, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $11 → $14 | $13.40 | +4.48% | 8 | May 13, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $10.57 | - | 3 | May 6, 2025 | |
| PRVA Privia Health Group | Reiterates: Market Outperform | $29 | $22.39 | +29.52% | 4 | Apr 28, 2025 | |
| EVH Evolent Health | Reiterates: Market Outperform | $13 | $8.49 | +53.12% | 8 | Apr 28, 2025 | |
| AGL agilon health | Reiterates: Market Perform | n/a | $2.10 | - | 4 | Apr 28, 2025 | |
| USPH U.S. Physical Therapy | Reiterates: Market Outperform | $113 | $74.45 | +51.78% | 2 | Apr 22, 2025 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 | $31.84 | +13.07% | 4 | Apr 22, 2025 | |
| ADUS Addus HomeCare | Maintains: Market Outperform | $150 | $114.23 | +31.31% | 2 | Apr 10, 2025 | |
| AXGN Axogen | Maintains: Market Outperform | $20 → $26 | $9.53 | +172.82% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $215.14 | +15.27% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $34 → $33 | $21.99 | +50.07% | 10 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $27.41 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $13.78 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.53 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $18.32 | - | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.34 | +291.79% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $1.22 | +10,145.90% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $20.07 | -25.26% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $21.44 | +4.94% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $2.35 | +261.70% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.30 | +976.92% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $7.39 | +4,771.45% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $540 | $5.08 | +10,529.92% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.80 | +4,906.26% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.65 | +820.25% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $80 | $1.03 | +7,666.99% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $0.02 | +90,397.74% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.99 | +8,503.24% | 2 | Sep 23, 2022 |
HealthEquity
Jun 4, 2025
Maintains: Market Outperform
Price Target: $110 → $117
Current: $100.01
Upside: +16.99%
OptimizeRx
May 13, 2025
Maintains: Market Outperform
Price Target: $11 → $14
Current: $13.40
Upside: +4.48%
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $10.57
Upside: -
Privia Health Group
Apr 28, 2025
Reiterates: Market Outperform
Price Target: $29
Current: $22.39
Upside: +29.52%
Evolent Health
Apr 28, 2025
Reiterates: Market Outperform
Price Target: $13
Current: $8.49
Upside: +53.12%
agilon health
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $2.10
Upside: -
U.S. Physical Therapy
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $74.45
Upside: +51.78%
Option Care Health
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $36
Current: $31.84
Upside: +13.07%
Addus HomeCare
Apr 10, 2025
Maintains: Market Outperform
Price Target: $150
Current: $114.23
Upside: +31.31%
Axogen
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $9.53
Upside: +172.82%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $215.14
Upside: +15.27%
Feb 24, 2025
Maintains: Market Outperform
Price Target: $34 → $33
Current: $21.99
Upside: +50.07%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $27.41
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $13.78
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $21.53
Upside: -
Jul 16, 2024
Initiates: Market Perform
Price Target: n/a
Current: $18.32
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.34
Upside: +291.79%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $1.22
Upside: +10,145.90%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $20.07
Upside: -25.26%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $21.44
Upside: +4.94%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $2.35
Upside: +261.70%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.30
Upside: +976.92%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $7.39
Upside: +4,771.45%
Apr 13, 2023
Reiterates: Buy
Price Target: $540
Current: $5.08
Upside: +10,529.92%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.80
Upside: +4,906.26%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.65
Upside: +820.25%
Sep 28, 2022
Maintains: Buy
Price Target: $140 → $80
Current: $1.03
Upside: +7,666.99%
Sep 28, 2022
Maintains: Buy
Price Target: $40 → $20
Current: $0.02
Upside: +90,397.74%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.99
Upside: +8,503.24%